The control of viral infection by tripartite motif proteins and cyclophilin A.
about
Common genetic variation and the control of HIV-1 in humansHow SAMHD1 changes our view of viral restrictionTRIM family proteins and their emerging roles in innate immunityHIV type 1 Gag as a target for antiviral therapyIndependent evolution of an antiviral TRIMCyp in rhesus macaquesEvolution of foamy viruses: the most ancient of all retrovirusesPharmacological inhibition of feline immunodeficiency virus (FIV)TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A proteinParallel Germline Infiltration of a Lentivirus in Two Malagasy LemursThe Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus ReplicationTRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conservedProton-driven Assembly of the Rous Sarcoma Virus Capsid Protein Results in the Formation of Icosahedral ParticlesConformational Adaptation of Asian Macaque TRIMCyp Directs Lineage Specific Antiviral ActivityDiscovery of Novel Small-Molecule HIV-1 Replication Inhibitors That Stabilize Capsid ComplexesLentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infectionImmunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membraneTarget cell cyclophilins facilitate human papillomavirus type 16 infectionEvolution of a TRIM5-CypA splice isoform in old world monkeysThe structural biology of HIV assembly.Quantitative TaqMan real-time PCR assays for gene expression normalisation in feline tissues.Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals.Gene expression analyses in Atlantic salmon challenged with infectious salmon anemia virus reveal differences between individuals with early, intermediate and late mortalityCellular proteins in influenza virus particles25 years of HIV-1 research - progress and perspectives.Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors.Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.Identification of a gp41 core-binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitor.Novel approaches to inhibiting HIV-1 replication.FIV Gag: virus assembly and host-cell interactions.AAV's anatomy: roadmap for optimizing vectors for translational successMutagenesis analysis of the zinc-finger antiviral proteinThe macrophage in HIV-1 infection: from activation to deactivation?Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activationThe specificity of TRIM5 alpha-mediated restriction is influenced by its coiled-coil domain.Transcriptomics of a giant freshwater prawn (Macrobrachium rosenbergii): de novo assembly, annotation and marker discovery.Innate immunity against HIV: a priority target for HIV prevention researchHigh natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier.Hare TRIM5α restricts divergent retroviruses and exhibits significant sequence variation from closely related lagomorpha TRIM5 genesNovel factors interfering with human immunodeficiency virus-type 1 replication in vivo and in vitro.
P2860
Q21092450-73137E94-CCF9-4D85-80D3-ECEBF8329AF6Q24605899-7F5B2946-619D-4D31-9B1C-FC33F201A4B6Q24607229-C40C6F34-B1D8-45A3-B75F-4F4B4DDB395CQ24614498-E1A0D8D5-8BA2-4291-8EE4-B7AD56FDBEE5Q24656091-DC47F7BA-8510-4F63-9BA3-434290949A63Q26852372-6175E7E6-AD73-4DC2-9BA1-3E4B84FEAF2BQ26995310-4783D967-8AEB-410D-8323-85859F88E174Q27468803-25B96537-18D9-4E5C-AD5B-B343F20E69C8Q27487981-E89923E6-86EB-42E2-852A-6345574FBFD0Q27489053-6DFE8306-1614-488C-B545-8E5A689FF7DBQ27650357-7633FF6B-C799-493A-8001-09850A4884EBQ27660228-B053CB22-B4A3-4460-9553-02268C0ACA81Q27664241-1F12B5B5-FBD5-4203-9FFB-EB6CD7172516Q27678859-71744D3A-987B-437F-8CF4-A4E3424C3EC2Q28472652-0E1D766B-6005-4C3D-98A2-8C769ABC6456Q28472771-3F75C86F-A135-448E-9155-7B399A4D2D31Q28475787-24B3678A-4771-42B4-AA9B-3EE7CC2A3097Q28755216-FB4C458F-2C89-4C4A-812A-566D35B51907Q30437103-E0584E97-A2AB-4FE5-BF1A-5D95542B3966Q30492706-4BB6B66C-483E-4C64-8EE9-35EFC9764377Q30839843-AC55F35B-A284-4252-8084-07B23E2ACD18Q33329258-9FB851D1-D05B-42E2-A8DF-AFF62EBF6ADCQ33340974-2C429F90-1FDA-4405-9886-7D3C48409D88Q33381841-53BC4BC3-776F-460C-B7A2-5E52F26C8DAEQ33407011-F550A3D1-5EC7-4239-B68D-6A4BCEFA17E7Q33602830-3D6F4BD4-6916-4619-B57A-82456714FDF8Q33622229-9EE42C09-D99B-450B-BD49-F4A578D0BEF7Q33624690-AA3CEDD3-FCE8-42BB-AE42-C524CCD5BC01Q33653971-E7E2BF36-B3CE-416E-B795-16ED6DC8A6BFQ33659389-4499AED0-B017-42C2-9ECA-2D889BC5FF00Q33761532-10B24CEE-5DB6-4F26-B79D-9B98D8C6C253Q33810779-1712808F-AD80-47ED-AD80-74594E61F2DEQ33826918-F3720D1B-2C44-4DE2-845F-D06AE3CDC211Q33865132-CB084111-C548-4DF7-99E6-C1632C1A437DQ33877357-8027CAC6-D980-491A-A6A3-CAD4AF1F9578Q34102915-A877E624-4293-4A15-A46B-91E0BF525479Q34243462-F332D03B-DECA-409E-AB16-45637BA1936CQ34291018-C3540CEE-B722-4800-864C-62AD51D6296BQ34291026-3D5997FA-3F25-44A9-A9C3-B5AFA3FFEC36Q34323296-6ED0D649-1621-4DA5-95E2-5F7DC401B7C8
P2860
The control of viral infection by tripartite motif proteins and cyclophilin A.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The control of viral infection by tripartite motif proteins and cyclophilin A.
@en
type
label
The control of viral infection by tripartite motif proteins and cyclophilin A.
@en
prefLabel
The control of viral infection by tripartite motif proteins and cyclophilin A.
@en
P2860
P921
P356
P1433
P1476
The control of viral infection by tripartite motif proteins and cyclophilin A
@en
P2093
Greg J Towers
P2860
P2888
P356
10.1186/1742-4690-4-40
P50
P577
2007-06-12T00:00:00Z
P5875
P6179
1017502818